<p>(A) Western blot for ErbB1 (EGFR) and ErbB2 (Her2) levels in adhered β-Gal or PERKΔC cells show increased levels when PERK is inhibited. GAPDH was used as loading control. (B) β-Gal or PERKΔC cells were injected orthotopically into the contralateral abdominal mammary fat pads of 3 week-old female nude mice (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0000615#s4" target="_blank">methods</a> for details). Post-implantation mice were monitored biweekly for tumor take and when detected tumor diameters were measured and the volume was calculated and plotted as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0000615#s4" target="_blank">methods</a>. Note that none of the mice impl...
Breast cancer remains a complex disease that kills 40,000 women every year. Initiation and progressi...
Human breast cancer cell lines MCF-7 (HTB-22), T47D (HTB-133), MDA-MB-231 (HTB-26) and SKBR3 (HTB-30...
To evaluate the extent to which each estrogen receptor (ER) subtype contributes to the stimulation o...
BACKGROUND: A significant proportion of breast cancer patients face failure of endocrine therapy due...
<p>MCF-7-MEK5 cells were transfected with empty vector or ERK5 shRNA. Decreased expression of ERK5 w...
<p>(A) Tumor volume measurement for mammary fat pad tumors grown from injection of shControl, PAR34 ...
A significant proportion of breast cancer patients face failure of endocrine therapy due to the acqu...
<p>MTT assay of MCF-10A, NMuMG and BME-UV cells at 0 h, 24 h and 48 h. Cells were cultivated in thei...
<p>(A) Growth of tumor volume in SE and EE mice, EE decreased tumor growth rate (n = 10–12 per group...
<p>(A) Phase contrast images and quantification of mammosphere-forming potency of MCF7ras and T47D c...
<p>Western-blot analysis of ErbB2, EGFR and Met expression in mammary tumors obtained from three sep...
Background: The ErbB2/Her2/Neu receptor tyrosine kinase is amplified in ~30 % of human breast cancer...
<p>Mice were subcutaneously injected with 10<sup>7</sup> Ba/F3-mock cells (left flank) and Ba/F3-BCR...
<p>Female athymic nu/nu mice were ovariectomized and subcutaneously implanted with either an estradi...
<p>MCF10DCIS.com and SUM-225 cells were treated with DAPT 1–10 µM (A) or Lapatinib 0.25–2.5 µM (B) i...
Breast cancer remains a complex disease that kills 40,000 women every year. Initiation and progressi...
Human breast cancer cell lines MCF-7 (HTB-22), T47D (HTB-133), MDA-MB-231 (HTB-26) and SKBR3 (HTB-30...
To evaluate the extent to which each estrogen receptor (ER) subtype contributes to the stimulation o...
BACKGROUND: A significant proportion of breast cancer patients face failure of endocrine therapy due...
<p>MCF-7-MEK5 cells were transfected with empty vector or ERK5 shRNA. Decreased expression of ERK5 w...
<p>(A) Tumor volume measurement for mammary fat pad tumors grown from injection of shControl, PAR34 ...
A significant proportion of breast cancer patients face failure of endocrine therapy due to the acqu...
<p>MTT assay of MCF-10A, NMuMG and BME-UV cells at 0 h, 24 h and 48 h. Cells were cultivated in thei...
<p>(A) Growth of tumor volume in SE and EE mice, EE decreased tumor growth rate (n = 10–12 per group...
<p>(A) Phase contrast images and quantification of mammosphere-forming potency of MCF7ras and T47D c...
<p>Western-blot analysis of ErbB2, EGFR and Met expression in mammary tumors obtained from three sep...
Background: The ErbB2/Her2/Neu receptor tyrosine kinase is amplified in ~30 % of human breast cancer...
<p>Mice were subcutaneously injected with 10<sup>7</sup> Ba/F3-mock cells (left flank) and Ba/F3-BCR...
<p>Female athymic nu/nu mice were ovariectomized and subcutaneously implanted with either an estradi...
<p>MCF10DCIS.com and SUM-225 cells were treated with DAPT 1–10 µM (A) or Lapatinib 0.25–2.5 µM (B) i...
Breast cancer remains a complex disease that kills 40,000 women every year. Initiation and progressi...
Human breast cancer cell lines MCF-7 (HTB-22), T47D (HTB-133), MDA-MB-231 (HTB-26) and SKBR3 (HTB-30...
To evaluate the extent to which each estrogen receptor (ER) subtype contributes to the stimulation o...